We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Electrical-First Strategy for AF Results in Shorter Hospitalization

By HospiMedica International staff writers
Posted on 22 Sep 2019
A new study suggests that in emergency department (ED) treatment of uncomplicated atrial fibrillation (AF) patients, electrical‐first strategy results in a significantly shorter length of stay (LOS).

Researchers at the University of Alberta (Edmonton, Canada), the University of British Columbia (UBC; Vancouver, Canada), and other institutions conducted a study involving 84 patients (18-75 years of age) with uncomplicated symptomatic AF of less than 48 hours. More...
The patients were randomized to either chemical cardioversion with procainamide infusion, followed by electrical countershock if unsuccessful; or to electrical cardioversion, followed by procainamide infusion if unsuccessful. The primary outcome was the proportion of patients discharged within four hours of arrival.

In all, 41patients in the chemical‐first group and 43 in the electrical‐first group were treated, with group composition balanced in terms of age, sex, vital signs, and CHADS2 scores. The results revealed that in the chemical‐first group, 32% were discharged within four hours of ED admittance, compared to 67% in the electrical‐first group. In the chemical‐first group, median LOS was 5.1 hours, compared to 3.5 hours in the electrical‐first group. No patients experienced stroke or death, and 99% were discharged with normal sinus rhythm. The study was published in the September 2019 issue of Academic Emergency Medicine.

“While both chemical‐first and electrical‐first cardioversion of uncomplicated AF appear very low risk, we sought to determine if one strategy resulted in the achievement of sinus rhythm and resulting discharge more quickly,” concluded lead author Frank Scheuermeyer, MD, MHSc, of UBC, and colleagues. “An electrical‐first strategy results in a significantly shorter ED LOS. This could benefit patients by restoring normal physiology more quickly to minimize ED resource use.”

The 2011 Canadian Cardiovascular Society (CCS) guidelines permit either rate or rhythm control for AF dysrhythmia patients encountered in the ED; the majority of patients undergo rhythm control, with one of two strategies employed. Chemical cardioversion can be attempted first, typically with procainamide infusion; if this approach restores sinus rhythm, the patient is discharged. If unsuccessful, procedural sedation and electrical countershock are administered. Alternatively, the sequence can be reversed.

Related Links:
University of Alberta
University of British Columbia


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.